Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: <i>in situ</i> and <i>ex vivo</i> 3.0 T MRI assessment-Reference-Cited by-同舟云学术

Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: in situ and ex vivo 3.0 T MRI assessment

Published:2023-11-01 Issue:1 Volume:111 Page:
ISSN:0007-1323
Container-title:British Journal of Surgery
language:en
Short-container-title:

Author:

Zhao Lijun¹,Zhu Xiangzhi¹,Jiang Ning¹,Zhang Jingyuan²,Kong Cheng¹,Xu Qicen¹,Gu Lingling³,Xie Xiaodong³,Jiang Ming⁴,Guo Zhen³^ORCID

Affiliation:

1. Department of Radiation Oncology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research , Nanjing , China

2. Department of Pathology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research , Nanjing , China

3. Department of Radiology, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research , Nanjing , China

4. Department of Thoracic Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research , Nanjing , China

Funder

Wujieping Medical Foundation

Publisher

Oxford University Press (OUP)

Subject

Surgery

Link

https://academic.oup.com/bjs/article-pdf/111/1/znad363/55122199/znad363.pdf

Reference5 articles.

1. Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer;Vollenbrock;Br J Surg,2019

2. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy;Heethuis;Radiother Oncol,2016

3. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypToNo) after neoadjuvant chemoradiation therapy?;Sassen;Eur Radiol,2013

4. Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis;van Rossum;Gastrointest Endosc,2016

5. Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis;Han;Ann Nucl Med,2021